Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants residing in the USA using Ion Torrent full-gene sequencing

Epidemiology and Infection

Volumn 142, Issue 6, 2014, Pages 1328-1333

  Daum, L T ^a   Fischer, G W ^a   Sromek, J ^b   Khubbar, M ^b   Hunter, P ^b,c   Gradus, M S ^b   Bhattacharyya, S ^b  

^a Longhorn Vaccines and Diagnostics   (United States)

^b City of Milwaukee Health Department   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Drug resistance genes; Ion Torrent sequencing; MDR; Mycobacterium tuberculosis; next generation sequencing

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING) A; ETHAMBUTOL; ISONIAZID; KATG PROTEIN; LEVOFLOXACIN; MOXIFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT;

ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BURMESE; CASE REPORT; CONTROLLED STUDY; DNA MICROARRAY; DRUG SENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; GYRA GENE; HMONG (PEOPLE); HUMAN; IMMIGRANT; INDIAN; INHA GENE; KATG GENE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PNCA GENE; PUBLIC HEALTH; RPOB GENE; RPSL GENE; RRS GENE; TUBERCULOSIS; UNITED STATES; UNSPECIFIED SIDE EFFECT; YOUNG ADULT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EMIGRANTS AND IMMIGRANTS; GENOME, BACTERIAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; MYANMAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT; WISCONSIN;

EID: 84898866575     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813002409     Document Type: Article

References (16)

1. World Health Organization. WHO report 2010: multi-drug and extensively drug-resistant TB (MDR-/XDR-TB). Global Report on Surveillance and Response. Geneva: WHO, WHO/HTM/TB/2010· 3, 2010.
2. Centers for Diseases Control and Prevention. Reported tuberculosis in the United States (http://www.cdc.gov/tb/statistics/reports/2011/pdf/report2011. pdf). Accessed February 2013.
3. Daum LT, et al. Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains. Journal of Clinical Microbiology 2012; 50: 3831-3837.
4. Desjardin LE, et al. Comparison of the ABI 7700 system (TaqMan) and competitive for quantification of IS6110 DNA in sputum during treatment of tuberculosis. Journal of Clinical Microbiology 1998; 36: 1964-1968.
5. Alcaide R, et al. Evaluation of the BACTEC MGIT 960 and MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. Journal of Clinical Microbiology 2009; 38: 398-340.
6. Zhang Y, Vilcheze C, Jacobs WR. Jr. Mechanisms of drug resistance in Mycobacterium tuberculosis. In: Tuberculosis and the Tubercle Bacillus. Washington, DC: ASM Press, 2009, pp. 115-140.
7. Mokrousov I, et al. High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996-2001. Antimicrobial Agents and Chemotherapy 2002; 46: 1417-1424.
8. Ho YM, et al. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant mycobacterium tuberculosis isolates. Antimicrobial Agents and Chemotherapy 2009; 53: 4010-4012.
9. Lee KW, Lee JM, Jung KS. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. Journal of Korean Medical Science 2001; 16: 537-543.
10. Lemaitre N, et al. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA. Antimicrobial Agents and Chemotherapy. 1999; 43: 1761-1763.
11. Mphahlele M, et al. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. Journal of Clinical Microbiology 2008; 46: 3459-3464.
12. Denkin S, et al. Microarray-based pncA genotyping of pyrazinamide- resistant strains of Mycobacterium tuberculosis. Journal of Medical Microbiology 2005; 54: 1127-1131.
13. Zhang Y, Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In: Molecular Genetics of Mycobacteria. Washington, DC: ASM Press, 2000, pp. 235-253.
14. Chang K, et al. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-Analysis. Journal of Infection 2012; 64: 580-588.
15. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. Journal of Clinical Microbiology 2007; 45: 2635-2640.
16. Daum LT, et al. Next-generation ion torrent sequencing of pyrazinamide resistance in MDR/XDR South African Mycobacterium tuberculosis strains [Abstract]. American Society for Microbiology (ASM) General Meeting, Denver, CO, USA, 18-21 May 2013.